341.20
+2.3(+0.68%)
Currency In INR
| Previous Close | 338.9 |
| Open | 340.2 |
| Day High | 343.5 |
| Day Low | 338.2 |
| 52-Week High | 406 |
| 52-Week Low | 291 |
| Volume | 1.7M |
| Average Volume | 4.03M |
| Market Cap | 455.35B |
| PE | 105.96 |
| EPS | 3.22 |
| Moving Average 50 Days | 366.16 |
| Moving Average 200 Days | 352.58 |
| Change | 2.3 |
If you invested ₹1000 in Biocon Limited (BIOCON.NS) 10 years ago, it would be worth ₹4,808.34 as of September 29, 2025 at a share price of ₹341.2. Whereas If you bought ₹1000 worth of Biocon Limited (BIOCON.NS) shares 5 years ago, it would be worth ₹755.69 as of September 29, 2025 at a share price of ₹341.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
GlobeNewswire Inc.
Jul 15, 2025 7:25 PM GMT
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today annou